These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10854804)

  • 21. European recommendations for antimicrobial resistance surveillance.
    Cornaglia G; Hryniewicz W; Jarlier V; Kahlmeter G; Mittermayer H; Stratchounski L; Baquero F;
    Clin Microbiol Infect; 2004 Apr; 10(4):349-83. PubMed ID: 15059129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance monitoring projects for zoonotic and indicator bacteria of animal origin: common aspects and differences between EASSA and EFSA.
    Moyaert H; de Jong A; Simjee S; Thomas V
    Vet Microbiol; 2014 Jul; 171(3-4):279-83. PubMed ID: 24674741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The state of antibiotic resistance surveillance: an overview of existing activities and new strategies.
    Davis SR
    Mil Med; 2000 Jul; 165(7 Suppl 2):35-9. PubMed ID: 10920636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Establishment of the Colombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS): A Pilot Project on Poultry Farms, Slaughterhouses and Retail Market.
    Donado-Godoy P; Castellanos R; León M; Arevalo A; Clavijo V; Bernal J; León D; Tafur MA; Byrne BA; Smith WA; Perez-Gutierrez E
    Zoonoses Public Health; 2015 Apr; 62 Suppl 1():58-69. PubMed ID: 25903494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations.
    Hughes JM; Tenover FC
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S131-5. PubMed ID: 8994792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surveillance and prevalence of antimicrobial resistance in Norway].
    Simonsen GS
    Tidsskr Nor Laegeforen; 2009 Mar; 129(7):623-7. PubMed ID: 19337330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ECDC publishes its first data on antimicrobial consumption in Europe.
    Weist K;
    Euro Surveill; 2013 Mar; 18(10):20419. PubMed ID: 23515063
    [No Abstract]   [Full Text] [Related]  

  • 28. Determining the value of antimicrobial surveillance programs.
    Jones RN; Masterton R
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):171-5. PubMed ID: 11777655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance patterns of Haemophilus influenzae.
    Acar JF
    J Chemother; 1999 Feb; 11 Suppl 1():44-50. PubMed ID: 10207773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the quality of the Alexander Project.
    Jacobs MR
    J Chemother; 1999 Feb; 11 Suppl 1():26-34. PubMed ID: 10207771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [International surveillance of antimicrobial resistance in Europe: now we also need to monitor antibiotic use].
    Bronzwaer SL; Buchholz U; Kool JL
    Euro Surveill; 2001 Jan; 6(1):1-2. PubMed ID: 11682704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance and future of antimicrobial surveillance studies.
    Masterton R
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S21-31. PubMed ID: 18713046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):72-89. PubMed ID: 9562116
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000.
    Cantón R; Loza E; Morosini MI; Baquero F
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():9-24. PubMed ID: 12239225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of antimicrobial resistance in Canada.
    Blondeau JM; Vaughan D
    Can J Microbiol; 2000 Oct; 46(10):867-77. PubMed ID: 11068672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European recommendations on surveillance of antituberculosis drug resistance.
    Wkly Epidemiol Rec; 2001 Jan; 76(1):2-5. PubMed ID: 11206027
    [No Abstract]   [Full Text] [Related]  

  • 37. Bacterial resistance to ciprofloxacin in Greece: results from the National Electronic Surveillance System. Greek Network for the Surveillance of Antimicrobial Resistance.
    Vatopoulos AC; Kalapothaki V; Legakis NJ
    Emerg Infect Dis; 1999; 5(3):471-6. PubMed ID: 10341191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of antimicrobial resistance: the WHONET program.
    Stelling JM; O'Brien TF
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S157-68. PubMed ID: 8994799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010-2016.
    Rodloff AC; Dowzicky MJ
    Anaerobe; 2018 Jun; 51():78-88. PubMed ID: 29679648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic resistance monitoring: a laboratory perspective.
    Trevino S
    Mil Med; 2000 Jul; 165(7 Suppl 2):40-2. PubMed ID: 10920637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.